Created in 2013 (United States), CLATAZEV own 496 sister brands and 17477 competing brands. CLATAZEV is owned by BRISTOL-MYERS SQUIBB COMPANY, listed on the stock exchange of New York CLATAZEV belongs to the Drug Manufacturers business sector.

CLATAZEV is a brand of BRISTOL-MYERS SQUIBB COMPANY (BMY) Share price

Share price and profitability of the share BRISTOL-MYERS SQUIBB COMPANY (CLATAZEV)

Buy BRISTOL-MYERS SQUIBB COMPANY share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 48.26

Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY (CLATAZEV) over 5 years* USD 51.16

Stock market history BRISTOL-MYERS SQUIBB COMPANY (CLATAZEV)

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more